(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ: MACK) dropped by a staggering 15.72% in 7 days from $4.39 to $3.70 at 11:27 EST on Friday, after five successive sessions in a row of losses. NASDAQ is sliding 1.71% to $10,877.76, after three consecutive sessions in a row of losses.

Merrimack Pharmaceuticals’s last close was $3.77, 49.12% under its 52-week high of $7.41.

About Merrimack Pharmaceuticals

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical business. It was founded in 1993. The headquarters are located in Cambridge, Massachusetts.


Today’s last reported volume for Merrimack Pharmaceuticals is 2915 which is 90.08% below its average volume of 29406.


Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.40%, a positive 0.37%, and a positive 2.61%, respectively.

Merrimack Pharmaceuticals’s highest amplitude of average volatility was 3.30% (last week), 2.10% (last month), and 2.61% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Merrimack Pharmaceuticals’s stock is considered to be overbought (>=80).

Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value

Merrimack Pharmaceuticals’s stock is valued at $3.70 at 11:28 EST, way under its 52-week high of $7.41 and higher than its 52-week low of $3.66.

Merrimack Pharmaceuticals’s Moving Average

Merrimack Pharmaceuticals’s worth is way under its 50-day moving average of $4.67 and way under its 200-day moving average of $5.22.

More news about Merrimack Pharmaceuticals (MACK).


Please enter your comment!
Please enter your name here